☆ 4.6 Article

IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer

BMC CANCER (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer A Randomized Phase 3 Clinical Trial

Yong Bae Kim et al.

Summary: The study found that adding internal mammary node irradiation to regional nodal irradiation did not significantly improve disease-free survival in patients with node-positive breast cancer. However, patients with medial or centrally located tumors may benefit from using internal mammary node irradiation.

JAMA ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy

Fei-Fei Xu et al.

Summary: This study investigated the clinical benefit of adjuvant radiotherapy after mastectomy in early-stage breast cancer patients. The results showed that high-risk patients had improved survival rates with adjuvant radiotherapy, while low-risk patients did not show significant survival benefits.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Mapping of PET/CT-based regional nodes distribution of recurrent/advanced breast cancer and comparison with current delineation atlas

Maochen Zhang et al.

Summary: The study aimed to localize the distribution of regional nodes in recurrent/advanced breast cancer patients and validate the coverage of clinical target volumes (CTVs) with current guidelines. The results showed that the current guidelines effectively covered most regional nodes, but missed some important regions such as SC-L and IMN. Recurrent ALNs were mainly located cranially and ventrally to the AV. The study contributes to the understanding of the differences in regional node delineation between current guidelines, particularly in the SC and IMN regions.

BRITISH JOURNAL OF RADIOLOGY (2022)

添加到收藏夹

Article Oncology

Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients

Yufei Zeng et al.

Summary: The 21-gene recurrence score (RS) assay is significantly associated with the risk of locoregional recurrence (LRR) in estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer patients. RS remains predictive of the risk of LRR among patients with different nodal statuses and patients receiving mastectomy.

CANCER BIOMARKERS (2022)

添加到收藏夹

Article Oncology

Prognostic value of the 21-gene recurrence score for regional recurrence in patients with estrogen receptor-positive breast cancer

Minji Koh et al.

Summary: The study evaluated the prognostic value of the 21-gene recurrence score (RS) for regional recurrence (RR) in patients with estrogen receptor-positive breast cancer. Results showed that high RS was an independent risk factor for RR, and patients with both high RS and clinical high-risk features had a significantly higher RR rate compared with other groups.

BREAST CANCER RESEARCH AND TREATMENT (2021)

添加到收藏夹

Article Multidisciplinary Sciences

The beneficial role of Asian-based RecurIndex test in the prognostic prediction in Chinese male breast cancer patients

Shuo Zhang et al.

Summary: The study found that RecurIndex testing can effectively predict the distant recurrence-free survival, progression-free survival, and overall survival of male breast cancer patients, helping to identify low-risk recurrence patients.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Oncology

Established and Validated Novel Nomogram for Predicting Prognosis of Post-Mastectomy pN0-1 Breast Cancer without Adjuvant Radiotherapy

Wei-Xiang Qi et al.

Summary: The study established a nomogram to predict the prognosis of breast cancer patients who underwent mastectomy without adjuvant radiotherapy, identifying significant predictors for breast cancer-specific survival and distant metastasis. The nomograms showed good accuracy in predicting 5-year outcomes across different datasets, providing a useful tool for identifying high-risk patients who may benefit from additional adjuvant therapy.

CANCER MANAGEMENT AND RESEARCH (2021)

添加到收藏夹

Article Oncology

Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay

Lina Zhang et al.

Summary: This study retrospectively analyzed the clinical data of 213 pT1-2N1M0 breast cancer patients and found that high-risk patients, especially those not receiving PMRT, had a significantly increased risk of recurrence and metastasis, leading to worse survival rates compared to low-risk patients. PMRT did not show benefits for low-risk patients, but demonstrated survival benefits for high-risk patients in terms of local-regional recurrence-free interval, distance recurrence-free interval, and overall survival rates.

INTERNATIONAL JOURNAL OF CANCER (2021)

添加到收藏夹

Article Surgery

PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2-disease: results from 1204 patients in the randomized ABCSG-8 trial

F. Fitzal et al.

Summary: The PAM-50 gene assay showed prognostic value for local recurrence risk in postmenopausal women with hormone receptor-positive breast cancer. Patients with a low risk score had significantly lower incidence of local recurrence compared to those in the high-risk group. The assay was not predictive of radiotherapy benefit in this cohort.

BRITISH JOURNAL OF SURGERY (2021)

添加到收藏夹

Article Oncology

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial

Philip M. Poortmans et al.

LANCET ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer

Naomi B. Boekel et al.

BRITISH JOURNAL OF CANCER (2018)

添加到收藏夹

Review Oncology

Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review

Jonathan E. Frandsen et al.

BREAST JOURNAL (2018)

添加到收藏夹

Article Oncology

Are There Patients With T1 to T2, Lymph Node-Negative Breast Cancer Who Are High-Risk for Locoregional Disease Recurrence?

Anita Mamtani et al.

CANCER (2017)

添加到收藏夹

Article Medicine, General & Internal

An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients

Skye H. Cheng et al.

EBIOMEDICINE (2016)

添加到收藏夹

Article Medicine, General & Internal

Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer

P. M. Poortmans et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?

Eunjin Jwa et al.

PLOS ONE (2015)

添加到收藏夹

Article Medicine, General & Internal

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

P. McGale et al.

LANCET (2014)

添加到收藏夹

Article Medicine, General & Internal

Postmastectomy internal mammary nodal irradiation: A long-term outcome

Eduardas Aleknavicius et al.

MEDICINA-LITHUANIA (2014)

添加到收藏夹

Article Oncology

Validating a Prognostic Scoring System for Postmastectomy Locoregional Recurrence in Breast Cancer

Skye Hung-Chun Cheng et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)

添加到收藏夹

Article Oncology

PATTERNS AND RISK FACTORS OF LOCOREGIONAL RECURRENCE IN T1-T2 NODE NEGATIVE BREAST CANCER PATIENTS TREATED WITH MASTECTOMY: IMPLICATIONS FOR POSTMASTECTOMY RADIOTHERAPY

Rita Abi-Raad et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

添加到收藏夹

Article Medicine, General & Internal

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials

LANCET (2011)

添加到收藏夹

Article Oncology

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor-Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

Eleftherios P. Mamounas et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Article Oncology

Genomic prediction of locoregional recurrence after mastectomy in breast cancer

Skye H. Cheng et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

添加到收藏夹

Article Medicine, General & Internal

Gene expression predictors of breast cancer outcomes

E Huang et al.

LANCET (2003)

添加到收藏夹

Article Oncology

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials

AC Voogd et al.

JOURNAL OF CLINICAL ONCOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.